Skip to main content

Table 4 BC survival analysis using a combination of the prognostic factors EP3 and BATMs

From: Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)

  OS% p value HR 95% CI DFS% p value HR 95% CI
A.
 EP3 high+BATM low 83.1     77.4    
 EP3 high+BATM high 70.0 0.059 2.128 0.973–4.658 66.7 0.326 1.437 0.697–2.962
 EP3 low+BATM low 58.1 0.01* 1.511 1.102–2.070 60.5 0.028* 1.405 1.037–1.902
 EP3 low+BATM high 35.0 0.000002* 1.756 1.391–2.217 60.0 0.000005* 1.922 1.453–2.544
B.
 BATM high+EP3 high 70.0     66.7    
 BATM high+EP3 low 35.0 0.023* 1.647 1.070–2.536 60.0 0.004* 2.107 1.264–3.513
C.
 BATM low+EP3 high 83.1     77.4    
 BATM low+EP3 low 58.1 0.01* 1.511 1.102–2.070 60.5 0.028* 1.405 1.037–1.902
D.
 EP3 high+BATM low 83.1     77.4    
 EP3 high+BATM high 70.0 0.059 2.128 0.973–4.658 66.7 0.326 1.437 0.697–2.962
E.
 EP3 low+BATM low 58.1     60.5    
 EP3 low+BATM high 35.0 0.007* 2.722 1.321–5.609 60.0 0.002* 4.049 1.665–9.847
  1. BATMs breast adipose tissue macrophage, EP3 prostaglandin E receptor 3, OS overall survival, DFS disease-free survival, p p value, HR hazard ratio, CI confidence interval; *significant (p value < 0.05)